CLEAR CELL CHONDROSARCOMA
Clinical trials for CLEAR CELL CHONDROSARCOMA explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL CHONDROSARCOMA trials appear
Sign up with your email to follow new studies for CLEAR CELL CHONDROSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare bone cancer? drug shows promise in early trial
Disease control OngoingThis phase 2 trial tested vismodegib, a pill that targets a specific growth pathway, in 45 people with advanced chondrosarcoma (a rare bone cancer). The goal was to see if the drug could shrink tumors or stop them from growing. Participants had to have measurable disease and no m…
Matched conditions: CLEAR CELL CHONDROSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Rare bone tumor under the microscope: can we predict its behavior?
Knowledge-focused OngoingThis study gathers information from 77 Italian patients with a rare, low-grade bone tumor called clear cell chondrosarcoma. Researchers will review medical records, imaging, and tissue samples to find patterns that might predict whether the tumor will come back or spread. The goa…
Matched conditions: CLEAR CELL CHONDROSARCOMA
Phase: NA • Sponsor: Istituto Ortopedico Rizzoli • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC